Amalgamated Bank Has $5.87 Million Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Amalgamated Bank lessened its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 25.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,092 shares of the company's stock after selling 18,247 shares during the quarter. Amalgamated Bank's holdings in Cardinal Health were worth $5,868,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Paragon Capital Management Inc. grew its stake in shares of Cardinal Health by 0.7% in the 2nd quarter. Paragon Capital Management Inc. now owns 14,758 shares of the company's stock valued at $1,451,000 after buying an additional 99 shares in the last quarter. Midland Wealth Advisors LLC lifted its holdings in Cardinal Health by 4.2% in the 2nd quarter. Midland Wealth Advisors LLC now owns 2,488 shares of the company's stock worth $245,000 after purchasing an additional 100 shares during the last quarter. Aptus Capital Advisors LLC lifted its holdings in Cardinal Health by 5.1% in the 2nd quarter. Aptus Capital Advisors LLC now owns 2,071 shares of the company's stock worth $204,000 after purchasing an additional 100 shares during the last quarter. Oregon Public Employees Retirement Fund lifted its holdings in Cardinal Health by 0.5% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 20,891 shares of the company's stock worth $2,054,000 after purchasing an additional 100 shares during the last quarter. Finally, Blair William & Co. IL lifted its holdings in Cardinal Health by 0.9% in the 2nd quarter. Blair William & Co. IL now owns 11,442 shares of the company's stock worth $1,125,000 after purchasing an additional 103 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Price Performance

Shares of NYSE CAH traded up $2.33 during trading hours on Friday, reaching $120.55. The stock had a trading volume of 2,790,847 shares, compared to its average volume of 2,089,549. The business's fifty day moving average is $112.07 and its two-hundred day moving average is $104.41. The company has a market cap of $29.17 billion, a price-to-earnings ratio of 23.46, a PEG ratio of 1.39 and a beta of 0.60. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $121.79.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The firm had revenue of $52.28 billion for the quarter, compared to analysts' expectations of $50.90 billion. During the same period in the prior year, the business posted $1.73 earnings per share. The business's revenue was down 4.3% compared to the same quarter last year. Sell-side analysts forecast that Cardinal Health, Inc. will post 7.84 earnings per share for the current fiscal year.

Cardinal Health Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a yield of 1.68%. The ex-dividend date of this dividend is Thursday, January 2nd. Cardinal Health's dividend payout ratio (DPR) is 39.30%.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Citigroup reduced their target price on Cardinal Health from $115.00 to $107.00 and set a "neutral" rating for the company in a report on Friday, July 19th. UBS Group boosted their target price on Cardinal Health from $134.00 to $139.00 and gave the stock a "buy" rating in a report on Monday. JPMorgan Chase & Co. upped their price target on Cardinal Health from $111.00 to $123.00 and gave the stock a "neutral" rating in a report on Wednesday, August 21st. StockNews.com lowered Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Sunday, November 3rd. Finally, Robert W. Baird upped their price target on Cardinal Health from $130.00 to $137.00 and gave the stock an "outperform" rating in a report on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, Cardinal Health has an average rating of "Moderate Buy" and a consensus target price of $123.00.

Insider Buying and Selling at Cardinal Health

In other Cardinal Health news, CFO Aaron E. Alt sold 2,323 shares of the company's stock in a transaction on Monday, August 19th. The stock was sold at an average price of $108.91, for a total value of $252,997.93. Following the sale, the chief financial officer now directly owns 36,867 shares in the company, valued at $4,015,184.97. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, insider Michelle D. Greene sold 4,000 shares of the stock in a transaction on Monday, August 19th. The stock was sold at an average price of $108.85, for a total transaction of $435,400.00. Following the sale, the insider now owns 19,242 shares in the company, valued at approximately $2,094,491.70. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Aaron E. Alt sold 2,323 shares of the stock in a transaction on Monday, August 19th. The stock was sold at an average price of $108.91, for a total value of $252,997.93. Following the sale, the chief financial officer now owns 36,867 shares in the company, valued at $4,015,184.97. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 113,963 shares of company stock worth $12,379,980 over the last three months. Company insiders own 0.09% of the company's stock.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.